Diversified Bio-Medics, Inc, (DBMI) is a private Nevada corporation whose head office is located at: 264 H. Street, Suite A, Blaine, WA.  98230.  DBMI was incorporated in 2003.

DBMI is addressing the current and emerging requirements for cGMP biomanufacturing capacity and expertise, both regionally and nationally. Through the company’s extensive network we will enable biotechnology companies to accelerate the development of candidate biopharmaceutical compounds to their next level of valuation by providing client/partners with turnkey access to comprehensive biological laboratory and manufacturing services that include validated cGMP biomanufacturing facilities, quality systems, and biological manufacturing expertise. The services offered by DBMI are designed to provide clients with pilot stage candidate biopharmaceutical materials, turnkey access to a validated laboratory and cGMP biomanufacturing operation for a rapid and quality assured pathway through its clinical study phases and into commercial production.

DBMI is planning to develop an 80-85,000 square foot, state-of-the-art bio-pharmaceutical manufacturing facility. The basic areas of use for a 80-85,000 sf facility would include 3 to 4 clean rooms, 4 to 5 individual production lines, and as much as 2 glass fill lines, 2 lyophilization lines and 1 batch fill.

At this time, Diversified is seeking to raise working capital specifically for the development of the Bio-manufacturing Facility. These funds will allow Diversified to complete:

• Feasibility Studies
• Market Evaluations
• Site Evaluations
• Cost Estimating
• Schematic Design
• Design Development
• Construction Documents and Specifications
• Construction Administration
• Design Work relating to handling and storage of hazardous production materials
• Site Evaluations and Suitability Analysis

For Corporate Information Contact:

Edward Onyon, VP

Business Development

Diversified Bio-Medics, Inc.

264 H Street, Suite A

Blaine, WA 98230

Ph. (360) 332-3210 / Fax (360) 332-3211

Email: edo@diversifiebiomedics.com

These web sites contains “forward-looking” statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934 as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Diversified Bio-Medics, Inc. Business Plan.  Except for the historical information contained herein, the matters discussed on this web site are forward-looking statements. These statements are made under "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See the Company's Business Plan which identifies specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.